Merck, Box Rose Premarket; Salesforce Falls

  • Investing.com
  • Stock Market News
Merck, Box Rose Premarket; Salesforce Falls

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Wednesday, December 1st. Please refresh for updates.

  • Salesforce (NYSE: CRM ) stock fell 6.5% after the software company provided disappointing current-quarter profit guidance in the face of stiff competition from rivals including Microsoft (NASDAQ: MSFT ). 

  • Merck (NS: PROR ) (NYSE: MRK ) stock rose 0.8% after a panel of advisers to the U.S. Food and Drug Administration voted to recommend the agency authorize the drugmaker's antiviral pill to treat Covid-19.

  • Box (NYSE: BOX ) stock rose 9.3% after the software company beat quarterly  expectations on both the top and bottom lines, helped by its performance in the Content Cloud market.

  • American Airlines (NASDAQ: AAL ) stock rose 1.6%, Delta (NYSE: DAL ) stock rose 2.2% and United (NASDAQ: UAL ) stock rose 1.8% as the airlines rebounded, while cruise operators Norwegian Cruise Line (NYSE: NCLH ), Carnival (NYSE: CCL ) (NYSE: CUK ) and Royal Caribbean (NYSE: RCL ) all rose more than 2.5%.

  • Exxon Mobil (NYSE: XOM ) stock rose 1.9%, Chevron (NYSE: CVX ) stock climbed 2% and Occidental Petroleum (NYSE: OXY ) stock rose 3.9% as crude prices soared more than 4%.

  • Allbirds (NASDAQ: BIRD ) stock fell 4.7% after the shoe retailer reported a wider loss despite a 33% jump in quarterly sales.

  • Hewlett Packard Enterprise (NYSE: HPE ) stock fell 1.4% after the information technology company topped profit expectations for its fiscal fourth-quarter earnings but issued first quarter earnings guidance that looked light.

  • Ambarella (NASDAQ: AMBA ) stock rose 15% after the semiconductor maker released a better-than-expected quarterly report, helped by strong sales of its computer-vision chips. 

  • Lennar (NYSE: LEN ) stock rose 3.8% after Goldman Sachs (NYSE: GS ) upgraded its investment stance on the real estate company to ‘buy’ from ‘neutral’, seeing 33% upside, thanks to sustained strong demand for new homes in the U.S.

  • DR Horton (NYSE: DHI ) stock fell 0.1% after Goldman downgraded its stance on the home construction company to ‘neutral’ from ‘buy’, saying upside in this stock is now limited.

 

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles